KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Prepaid Assets (2017 - 2025)

Aquestive Therapeutics (AQST) has 8 years of Prepaid Assets data on record, last reported at $4.2 million in Q4 2025.

  • For Q4 2025, Prepaid Assets rose 26.84% year-over-year to $4.2 million; the TTM value through Dec 2025 reached $4.2 million, up 26.84%, while the annual FY2025 figure was $4.2 million, 26.84% up from the prior year.
  • Prepaid Assets reached $4.2 million in Q4 2025 per AQST's latest filing, up from $2.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $4.2 million in Q4 2025 and bottomed at $1.2 million in Q2 2024.
  • Average Prepaid Assets over 5 years is $2.4 million, with a median of $2.1 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: tumbled 31.05% in 2023, then skyrocketed 77.24% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $3.1 million in 2021, then plummeted by 30.74% to $2.1 million in 2022, then dropped by 13.0% to $1.9 million in 2023, then surged by 77.24% to $3.3 million in 2024, then rose by 26.84% to $4.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $4.2 million in Q4 2025, $2.9 million in Q3 2025, and $1.2 million in Q2 2025.